Overview
- Editors:
-
-
Domenic A. Ciraulo
-
School of Medicine, Div. Psychiatry, Boston University, Boston, USA
-
Richard Irwin Shader
-
School of Medicine, Dept. Pharmacology &, Tufts University, Boston, USA
- Updated and expanded for the second edition
- Includes a new chapter on treatment of depression in the medically ill
- Covers the Star*D trial, a NIMH study on adults who do not respond to first treatment with medication
- Includes supplementary material: sn.pub/extras
Access this book
Other ways to access
Table of contents (11 chapters)
-
-
- David J. Goldstein, William Z. Potter, Domenic A. Ciraulo, Richard I. Shader
Pages 1-32
-
- Domenic A. Ciraulo, Richard I. Shader, David J. Greenblatt
Pages 33-124
-
- Domenic A. Ciraulo, James A. Evans, Wei Qiao Qiu, Richard I. Shader, Carl Salzman
Pages 125-183
-
- Oliver Freudenreich, Donald C. Goff
Pages 185-196
-
-
- John A. Renner, Jeffrey Baxter, Joji Suzuki, Domenic A. Ciraulo
Pages 239-274
-
- Janet E. Osterman, Brandon Z. Erdos, Mark Oldham, Ana Ivkovic
Pages 275-307
-
-
- Ricardo M. Vela, Carol A. Glod, Timothy M. Rivinus, Rebecca Johnson
Pages 355-374
-
- Larry Culpepper, Peggy Johnson
Pages 375-397
-
- Wei Jiang, K. Ranga Rama Krishnan
Pages 399-414
-
Back Matter
Pages 415-423
About this book
Comprehensive and state of the art, the second edition of Pharmacotherapy of Depression offers major revisions of every chapter and the addition of new chapters by expert contributors. The first chapter reviews the neurobiology of depression, which lays the groundwork for understanding the mechanisms of action of antidepressants. In the next chapter, a review of the general principles guiding the diagnosis and medication treatment of unipolar depression is provided. The clinical pharmacology of antidepressants is reviewed in some detail, supplemented by tables that provide information on dosing, indications, and metabolism. Augmentation strategies are reviewed, including the use of non-traditional agents. The chapters that follow next address the use of antidepressants in special populations, such as the elderly and depressed individuals with psychosis, bipolar disorder, substance abuse, and post traumatic stress disorder. The complex issues involving the diagnosis and treatment of depression during pregnancy is thoroughly reviewed in Chapter 8 and provides a synthesis of the scientific literature in the area, one that is noted for contradictory and controversial findings, as well as guidelines for prescribing. The next chapter then provides an overview of the treatment of depression in the pediatric population, highlighting clinical concerns such as suicide risk. The book concludes with two chapters at the interface of medicine and psychiatry in the treatment of mood disorders: managing depression in primary care settings and depression associated with medical illnesses. The outstanding clinician-scientists who have contributed to this volume are all leaders in their fields and represent a broad spectrum of renowned institutions. A timely contribution to the literature, The Pharmacotherapy of Depression, Second Edition, offers busy clinicians from many disciplines a strong scientific foundation that seamlessly transitions into practical recommendations for clinicalpractice. The result is another gold-standard guide to the safe and effective use of the latest antidepressant medications.
Reviews
From the reviews of the second edition:
“This is an update of a comprehensive book reviewing the neurobiological foundation and general principles and recommendations for the use of pharmacotherapy in the treatment of depression in a wide range of clinical presentations. … a broad intended audience that includes ‘practicing physicians, residents in psychiatry, neurology, and medicine as well as psychologists, medical students, social workers, nurses, mental health counselors and graduate students.’ … clinicians who use pharmacotherapeutic strategies to treat patients with depression will use this book the most.” (Aaron Plattner, Doody’s Review Service, May, 2011)
Editors and Affiliations
-
School of Medicine, Div. Psychiatry, Boston University, Boston, USA
Domenic A. Ciraulo
-
School of Medicine, Dept. Pharmacology &, Tufts University, Boston, USA
Richard Irwin Shader
